Inactive Instrument
Company Endologix, Inc. Nasdaq
Stocks
US29266S1069
Medical Equipment, Supplies & Distribution
Business description: Endologix, Inc.

Sales by Activity: Endologix, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
Development, Manufacture, Marketing and Sale of EVAR and EVAS Products | 143M |
Geographical breakdown of sales: Endologix, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States (U.S.) | 95.32M |
International | 48.05M |
Executive Committee: Endologix, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John Liddicoat
CEO | Chief Executive Officer | 62 | 2025-01-06 |
Cindy Pinto
DFI | Director of Finance/CFO | - | 2014-08-31 |
Graham Phillips
COO | Chief Operating Officer | - | 2024-06-17 |
Matt Poole
CTO | Chief Tech/Sci/R&D Officer | - | 2023-01-31 |
Hara Jorge
SAM | Sales & Marketing | - | 2025-03-31 |
Composition of the Board of Directors: Endologix, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | 44 | 2020-10-31 | |
Avi Kometz
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - | |
Lucas Buchanan
BRD | Director/Board Member | 48 | 2023-08-23 |
John Liddicoat
BRD | Director/Board Member | 62 | 2025-01-06 |
Arthur Taylor
BRD | Director/Board Member | 69 | 2024-01-24 |
Scott Ward
BRD | Director/Board Member | 66 | 2024-01-08 |
R. Huennekens
BRD | Director/Board Member | 61 | 2025-07-08 |
Company details: Endologix, Inc.

Medical Devices & Implants
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.50% | +4.86% | -15.63% | +11.28% | 126B | ||
| -1.36% | +2.88% | +2.36% | -3.80% | 12.87B | ||
| +0.72% | +11.10% | +49.21% | +116.03% | 8.84B | ||
| -0.46% | -0.37% | -49.18% | -73.25% | 3.87B | ||
| -1.81% | +3.71% | +20.09% | +40.77% | 2.65B | ||
| -1.60% | -2.24% | -12.94% | -19.85% | 1.8B | ||
| -1.01% | +1.33% | -2.43% | -25.57% | 1.61B | ||
| -7.31% | +18.01% | -31.92% | -63.26% | 1.47B | ||
| Average | -1.69% | +4.04% | -5.05% | -2.21% | 19.94B | |
| Weighted average by Cap. | -0.60% | +4.64% | -10.79% | +12.90% |

















